The Hepatitis B and C Public Policy Association is supported on an “invitation to treat” basis which is inclusive of public and private enterprises that may wish to participate.
The Sponsoring Partners to the Association’s activities will be contacted by its Directors at regular intervals in the interests of broad consultation, and will have access to the developing programme through regular progress reports and meetings. The Sponsoring Partners will not have any voting rights in the decisions taken by the Association.
Gilead Sciences Inc Europe, AbbVie Europe and MSD. We would like to thank these companies for their continued support.